Stock Updates

How has UnitedHealth Group Incorporated:(NYSE:UNH) performed recently?

UnitedHealth Group Incorporated (NYSE: UNH) is a large market cap stock with a market cap of 135707.98. It is in the Health Care Plans industry and sector Healthcare, with a current P/E of 22.4, a forward P/E of 15.8 and EPS of 6.39. At a stock price of 143.21 (0.03%) it has a dividend yield of 1.75%.

EPS growth for the last five years have been 8.00%, more recently this last year it has grown by 5.50%. The next year growth is going to be about 14.54% and more long-term 14.95% after five years. EPS growth quarter over quarter is 10.50%. Sales growth for the past five years have been 10.80% and sales growth quarter over quarter is 28.20%.

For performance, UnitedHealth Group Incorporated the past week has seen a gain of 1.04%. For the last month performance for UnitedHealth Group Incorporated is 1.64%. While the last quarter is 8.58% and half year, 26.81%. Finally for the year, performance is 20.50%.

The 52-week high for UnitedHealth Group Incorporated, is at -0.88%, and for the 52-week low it comes to a value of 53.38%. The 20-day simple moving average is 3.04% and 15.10% for the 200-day simple moving average.

Volatility for the week is at 1.32%, and for the month it is 1.38%. UnitedHealth Group Incorporated, has a target price of 160.65.

In terms of debt, long term debt/equity is 0.74, and for total debt/equity UnitedHealth Group Incorporated has 0.91. The gross margin is *TBA, while operating margin is 6.60%, the profit margin is 3.50%. The current ratio is *TBA and the quick ratio is *TBA.

Insider ownership is at 0.70%, with instituitional ownership at 90.10%. UnitedHealth Group Incorporated has a payout ratio of 23.20%. With the total shares outstanding coming to 947.88. The shares float is 931.67, with the float short at 0.86%, with short ratio coming to 2.5.

In terms of returns, the return on assets see UnitedHealth Group Incorporated, get 5.40%, with its returns on investment at 10.10%. Return on equity is 17.90%. So will the investors see the target price of 160.65, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment